Seifem

Publications

SEIFEM Publications

2020

INFECTIONS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES TREATED WITH TARGETED AGENTS: SEIFEM MULTICENTRIC RETROSPECTIVE STUDY.

2020

IMPACT OF INVASIVE ASPERGILLOSIS OCCURRING DURING FIRST INDUCTION THERAPY ON OUTCOME OF ACUTE MYELOID LEUKAEMIA (SEIFEM-12B STUDY).

2020

CANDIDAEMIA IN HAEMATOLOGICAL MALIGNANCY PATIENTS FROM A SEIFEM STUDY: EPIDEMIOLOGICAL PATTERNS ACCORDING TO ANTIFUNGAL PROPHYLAXIS.

2020

INFECTIONS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES TREATED WITH BRENTUXIMAB VEDOTIN: SEIFEM MULTICENTRIC RETROSPECTIVE STUDY.

2020

CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS IN ALLOGENEIC STEM CELL TRANSPLANTATION. OUTCOME OF 24 RECENT CASES AND LITERATURE REVIEW

2020

ISAVUCONAZOLE IN HEMATOLOGICAL PATIENTS: FINAL RESULTS OF A REAL-LIFE MULTICENTER OBSERVATIONAL SEIFEM STUDY

2019

A BAL-DRIVEN ANTIMICROBIAL TREATMENT IMPROVES CLINICAL OUTCOME IN HEMATOLOGIC MALIGNANCIES PATIENTS WITH LUNG INFILTRATES DETECTION: A PROSPECTIVE MULTICENTER STUDY OF THE SEIFEM GROUP

2019

EPIDEMIOLOGY AND CLINICAL OUTCOME OF FUNGAL INFECTIONS OF THE CENTRAL NERVOUS SYSTEM IN ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS

2020

RHODOTORULA INFECTION IN HAEMATOLOGICAL PATIENT: RISK FACTORS AND OUTCOME

2020

REAL-LIFE ANALYSIS OF THE ROLE OF ANTIFUNGAL PROPHYLAXIS IN PREVENTING INVASIVE ASPERGILLOSIS IN AML PATIENTS UNDERGOING CONSOLIDATION THERAPY: SORVEGLIANZA EPIDEMIOLOGICA INFEZIONI NELLE EMOPATIE (SEIFEM) 2016 STUDY

2020

A BRONCHOALVEOLAR LAVAGE-DRIVEN ANTIMICROBIAL TREATMENT IMPROVES SURVIVAL IN HEMATOLOGIC MALIGNANCY PATIENTS WITH DETECTED LUNG INFILTRATES: A PROSPECTIVE MULTICENTER STUDY OF THE SEIFEM GROUP

2020

BLOODSTREAM INFECTIONS CAUSED BY ESCHERICHIA COLI IN ONCO-HAEMATOLOGICAL PATIENTS: RISK FACTORS AND MORTALITY IN AN ITALIAN PROSPECTIVE SURVEY

2020

FUNGAL INFECTIONS OF THE CENTRAL NERVOUS SYSTEM AND PARANASAL SINUSES IN ONCO-HEMATOLOGIC PATIENTS. EPIDEMIOLOGICAL STUDY REPORTING THE DIAGNOSTIC-THERAPEUTIC APPROACH AND OUTCOME IN 89 CASES

2020

FUNGAEMIA IN HAEMATOLOGICAL MALIGNANCIES: SEIFEM-2015 SURVEY

2020

BLOODSTREAM INFECTIONS IN HAEMATOLOGICAL CANCER PATIENTS COLONIZED BY MULTIDRUG-RESISTANT BACTERIA

2018

FROM REAL LIFE TO AN AGREEMENT ON THE USE OF GRANULOCYTE TRANSFUSIONS AND COLONY-STIMULATING FACTORS FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANT DISORDERS.

2018

FROM REAL LIFE TO AN AGREEMENT ON THE USE OF GRANULOCYTE TRANSFUSIONS AND COLONY-STIMULATING FACTORS FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANT DISORDERS.

2019

SEIFEM 2016 STUDY: INCIDENCE OF PROBABLE AND PROVEN INVASIVE ASPERGILLOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA DURING CONSOLIDATION THERAPY

2019

SEIFEM 2016 STUDY: INCIDENCE AND MORTALITY OF PROBABLE AND PROVEN INVASIVE ASPERGILLOSIS DURING SALVAGE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA.

2019

SEIFEM 2015-B: INCIDENCE AND MORTALITY FOR CANDIDEMIA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES.

2019

FUNGAL INFECTIONS OF THE CENTRAL NERVOUS SYSTEM AND PARANASAL SINUSES IN HEMATOLOGIC PATIENTS. A SEIFEM GROUP STUDY REPORTING DIAGNOSTIC-THERAPEUTIC APPROACH AND OUTCOME IN 87 CASES

2019

SEIFEM 2016 STUDY: INCIDENCE OF PROBABLE AND PROVEN INVASIVE ASPERGILLOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA DURING CONSOLIDATION THERAPY.

2018

CHANGES IN THE INCIDENCE OF CANDIDEMIA AND RELATED MORTALITY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES IN THE LAST TEN YEARS. A SEIFEM 2015-B REPORT.

2018

ECONOMIC EVALUATION OF POSACONAZOLE FOR ANTIFUNGAL PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING INDUCTION CHEMOTHERAPY.

2018

RISK STRATIFICATION FOR INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: SEIFEM RECOMMENDATIONS.

2019

BLOODSTREAM INFECTIONS IN HEMATOLOGICAL CANCER PATIENTS COLONIZED BY MULTIRESISTANT BACTERIA: FINAL RESULTS OF A MULTICENTRIC PROSPECTIVE OBSERVATIONAL SEIFEM STUDY

2019

PRELIMINARY REPORT OF FUNGEMIA IN HEMATOLOGICAL MALIGNANCIES FROM SEIFEM-2015 SURVEY

2019

EPIDEMIOLOGY OF FUNGAEMIA IN HEMATOLOGICAL MALIGNANCIES: PRELIMINARY REPORT OF SEIFEM-2015 SURVEY.

2018

BLOODSTREAM INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE IN ONCO-HEMATOLOGICAL PATIENTS: CLINICAL IMPACT OF CARBAPENEM RESISTANCE IN A MULTICENTRE PROSPECTIVE SURVEY.

2018

SUCCESSFUL MANAGEMENT OF CHRONIC DISSEMINATED CANDIDIASIS IN HEMATOLOGIC PATIENTS TREATED WITH HIGH-DOSE LIPOSOMAL AMPHOTERICIN B: A RETROSPECTIVE STUDY OF THE SEIFEM REGISTRY

2019

BLOODSTREAM INFECTIONS IN HEMATOLOGICAL CANCER PATIENTS COLONIZED BY MULTIRESISTANT BACTERIA: RESULTS OF A MULTICENTRIC PROSPECTIVE OBSERVATIONAL SEIFEM STUDY

2019

EPIDEMIOLOGY OF FUNGEMIA IN HEMATOLOGICAL MALIGNANCIES: PRELIMINARY REPORT OF SEIFEM-2015 SURVEY

2019

BLOODSTREAM INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE IN ONCO-HEMATOLOGICAL PATIENTS: INCIDENCE AND CLINICAL IMPACT OF CARBAPENEM RESISTANCE IN A MULTICENTRE PROSPECTIVE SURVEY

2019

SEIFEM B 2012.A PROSPECTIC, MULTICENTRIC, OBSERVATIONAL STUDY ON FEBRILE EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIA. FINAL RESULTS

2019

SUCCESSFUL THERAPY OF CHRONIC DISSEMINATED CANDIDIASIS IN HEMATOLOGIC PATIENTS WITH HIGH-DOSE LIPOSOMAL AMPHOTERICIN B: A RETROSPECTIVE STUDY OF SEIFEM-REGISTRY

2019

CURRENT EPIDEMIOLOGY AND ANTIMICROBIAL RESISTANCE DATA FOR BACTERIAL BLOODSTREAM INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES: AN ITALIAN MULTICENTRE PROSPECTIVE SURVEY.

2018

SUCCESSFUL MANAGEMENT OF CHRONIC DISSEMINATED CANDIDIASIS IN HEMATOLOGIC PATIENTS TREATED WITH HIGH-DOSE LIPOSOMAL AMPHOTERICIN B: A RETROSPECTIVE STUDY OF THE SEIFEM REGISTRY

2018

PRE-CHEMOTHERAPY RISK FACTORS FOR INVASIVE FUNGAL DISEASES: PROSPECTIVE ANALYSIS OF 1,192 PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (SEIFEM 2010-A MULTICENTER STUDY).

2018

RISK OF INVASIVE FUNGAL INFECTION IN PATIENTS AFFECTED BY ACUTE PROMYELOCYTIC LEUKAEMIA. A REPORT BY THE SEIFEM-D REGISTRY.

2020

LONG-LASTING PROTECTIVE EFFECT OF POSACONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

2019

INVASIVE FUNGAL INFECTIONS IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS. RESULTS OF A PROSPECTIVE MULTICENTER STUDY IN ITALY

2018

SYSTEMIC ANTIFUNGAL TREATMENT AFTER POSACONAZOLE PROPHYLAXIS: RESULTS FROM THE SEIFEM 2010-C SURVEY.

2018

MULTICENTRE SURVEILLANCE STUDY ON FEASIBILITY, SAFETY AND EFFICACY OF ANTIFUNGAL COMBINATION THERAPY FOR PROVEN OR PROBABLE INVASIVE FUNGAL DISEASES IN HAEMATOLOGICAL PATIENTS: THE SEIFEM REAL-LIFE COMBO STUDY

2018

COMBINED ANTIFUNGAL APPROACH FOR THE TREATMENT OF INVASIVE MUCORMYCOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES: A REPORT FROM THE SEIFEM AND FUNGISCOPE REGISTRIES.

2018

NOCARDIA SPP INFECTIONS AMONG HEMATOLOGICAL PATIENTS: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY.

2019

COMBINATION THERAPY OF MUCORMYCOSIS IN HEMATOLOGY: AN ANALYSIS OF SEIFEM AND FUNGISCOPE REGISTER STUDIES

2018

COMBINED ANTIFUNGAL APPROACH FOR THE TREATMENT OF INVASIVE MUCORMYCOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES: A REPORT FROM THE SEIFEM AND FUNGISCOPE REGISTRIES.

2018

NOCARDIA SPP INFECTIONS AMONG HEMATOLOGICAL PATIENTS: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY.

2018

EVALUATION OF THE PRACTICE OF ANTIFUNGAL PROPHYLAXIS USE IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS FROM THE SEIFEM 2010-B REGISTRY.

2018

DERIVATION AND VALIDATION OF A SCORING SYSTEM TO IDENTIFY PATIENTS WITH BACTEREMIA AND HEMATOLOGICAL MALIGNANCIES AT HIGHER RISK FOR MORTALITY.

2019

PRE-HOSPITAL RISK FACTORS FOR INVASIVE FUNGAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AT DIAGNOSIS: PRELIMINARY RESULTS FROM THE SEIFEM 2010-STUDY

2018

MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTION IN ADULT PATIENTS WITH HEMATOLOGIC MALIGNANCIES.

2018

INVASIVE ASPERGILLOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SEIFEM-2008 REGISTRY STUDY.

2018

ADHERENCE TO INTERNATIONAL GUIDELINES FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS IN ACUTE MYELOID LEUKAEMIA: FEASIBILITY AND UTILITY (SEIFEM-2008B STUDY).

2019

INVASIVE ASPERGILLOSIS IN ACUTE MYELOID LEUKEMIA: REPORT OF SEIFEM-2008 MULTICENTER SURVEY

2019

EPIDEMIOLOGY OF FUNGAL INFECTIONS IN HEMATOLOGICAL MALIGNANCIES IN ITALY: SEIFEM-2004 STUDY (SORVEGLIANZA EPIDEMIOLOGICA INFEZIONI FUNGINE NELLE EMOPATIE MALIGNE).

2019

INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND IN THOSE SUBMITTED TO ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANT: WHO IS AT HIGHEST RISK?

2018

INVASIVE ASPERGILLOSIS IN PATIENTS WITH ACUTE LEUKEMIA: UPDATE ON MORBIDITY AND MORTALITY–SEIFEM-C REPORT

2018

FUNGAL INFECTIONS IN RECIPIENTS OF HEMATOPOIETIC STEM CELL TRANSPLANTS: RESULTS OF THE SEIFEM B-2004 STUDY–SORVEGLIANZA EPIDEMIOLOGICA INFEZIONI FUNGINE NELLE EMOPATIE MALIGNE.

2018

THE EPIDEMIOLOGY OF FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES: THE SEIFEM-2004 STUDY.